6 news items
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment
STXS
29 May 24
leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery
Stereotaxis Receives CE Mark Recertification Under EU's MDR Regulatory Framework
STXS
24 May 24
(NYSE:STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery
First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology
STXS
22 May 24
intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
STXS
15 May 24
leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery
Stereotaxis Reports 2024 First Quarter Financial Results
STXS
13 May 24
for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information
yz7dac6m45n7 p0wacoy0v7n3qqh4k34q85vz9cffudq6bozobktbv8t994
STXS
13 May 24
to continue contributing our unique expertise in high-quality EP catheters while also playing a central role in an exciting new mission of pioneering
- Prev
- 1
- Next